Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Endocrinology|March 18, 2003
Spatial distribution of the messenger ribonucleic acid and protein of the nuclear receptor coactivator, amplified in breast cancer-3, in miceHao Zhang, Lan Liao, Shao-Qing Kuang, et al.
Plos One|April 20, 2016
Recurrent Rare Genomic Copy Number Variants and Bicuspid Aortic Valve Are Enriched in Early Onset Thoracic Aortic Aneurysms and DissectionsSiddharth Prakash, Shao-Qing Kuang, , et al.
Cancer Research|October 7, 2004
Haploid inactivation of the amplified-in-breast cancer 3 coactivator reduces the inhibitory effect of peroxisome proliferator-activated receptor gamma and retinoid X receptor on cell proliferation and accelerates polyoma middle-T antigen-induced mammary tumorigenesis in miceHao Zhang, Shao-Qing Kuang, Lan Liao, et al.
Shi Yan Sheng Wu Xue Bao|September 4, 2004
A rapid and cost-effective screening method for identification of targeted embryonic stem cellsLan Liao, Shao Qing Kuang, Yu Hui Yuan, et al.
Seminars in Hematology|December 23, 2008
Epigenetics of acute lymphocytic leukemiaGuillermo Garcia-Manero, Hui Yang, Shao-Qing Kuang, et al.
Cancer Research|September 6, 2005
Mice lacking the amplified in breast cancer 1/steroid receptor coactivator-3 are resistant to chemical carcinogen-induced mammary tumorigenesisShao-Qing Kuang, Lan Liao, Shu Wang, et al.
The Journal of Steroid Biochemistry and Molecular Biology|March 26, 2003
Molecular structure and biological function of the cancer-amplified nuclear receptor coactivator SRC-3/AIB1Lan Liao, Shao-Qing Kuang, Yuhui Yuan, et al.
Cancer Research|March 5, 2004
AIB1/SRC-3 deficiency affects insulin-like growth factor I signaling pathway and suppresses v-Ha-ras-induced breast cancer initiation and progression in miceShao-Qing Kuang, Lan Liao, Hao Zhang, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 26, 2008
Disruption of the SRC-1 gene in mice suppresses breast cancer metastasis without affecting primary tumor formationShu Wang, Yuhui Yuan, Lan Liao, et al.
Leukemia Research|August 18, 2009
Preclinical antileukemia activity of JNJ-26481585, a potent second-generation histone deacetylase inhibitorWei-Gang Tong, Yue Wei, William Stevenson, et al.
Pageof 3